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Characterising chromosome rearrangements: recent
technical advances in molecular cytogenetics
S Le Scouarnec and SM Gribble
Genomic rearrangements can result in losses, ampliﬁcations, translocations and inversions of DNA fragments thereby modifying
genome architecture, and potentially having clinical consequences. Many genomic disorders caused by structural variation have
initially been uncovered by early cytogenetic methods. The last decade has seen signiﬁcant progression in molecular cytogenetic
techniques, allowing rapid and precise detection of structural rearrangements on a whole-genome scale. The high resolution
attainable with these recently developed techniques has also uncovered the role of structural variants in normal genetic variation
alongside single-nucleotide polymorphisms (SNPs). We describe how array-based comparative genomic hybridisation, SNP
arrays, array painting and next-generation sequencing analytical methods (read depth, read pair and split read) allow the
extensive characterisation of chromosome rearrangements in human genomes.
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INTRODUCTION
Diverse types of genomic variants have been described (Scherer et al.,
2007) thanks to the development and expansion of molecular biology
and cytogenetic techniques, and contribute largely to human disease,
normal phenotypic variation and karyotypic evolution. Structural
variants (SVs) within individual genomes result from chromosomal
rearrangements affecting at least 50bp (Alkan et al., 2011a) and
include deletions and duplications known as copy-number variants
(CNVs), inversions and translocations. Rearrangements are triggered
by multiple events including external factors such as cellular stress and
incorrect DNA repair or recombination (Mani and Chinnaiyan, 2010).
Notably, segmental duplications (low-copy repeats), which are parti-
cularly frequent in subtelomeric regions (Linardopoulou et al., 2005),
facilitate nonallelic homologous recombination and are considered as
hotspots for recurrent rearrangements (Mefford and Eichler, 2009;
Stankiewicz and Lupski, 2010; Ou et al., 2011).
The conventional cytogenetic methods, ‘chromosome banding’ and
‘karyotyping’ are very informative and are still commonly used.
However, these techniques are limited to the detection of numerical
chromosomal aberrations (aneuploidy, polyploidy) and microscopic
SVs a few megabases in size (Table 1). Molecular cytogenetic
approaches enable the detection of submicroscopic SVs and have
been crucial for studying complex rearrangements, generated by more
than two chromosomal breakage events, reﬁning breakpoints and
performing cross-species comparisons (Speicher and Carter, 2005).
These newer approaches have mostly relied on the use of ‘ﬂuorescence
in situ hybridisation’ (FISH; Bauman et al., 1980) where ﬂuorescence
microscopy reveals the presence and localisation of deﬁned labelled
DNA probes binding to complementary sequences on targets, tradi-
tionally metaphase chromosome spreads. To facilitate detection of
events such as translocations, whole chromosome-speciﬁc DNA
probes or ‘paints’ have been used (‘chromosome painting’; Cremer
et al., 1988; Lichter et al., 1988; Pinkel et al., 1988). To increase
resolution, shorter probes have been introduced (for example, fosmids
and very recently oligonucleotide libraries; Yamada et al., 2011) and/or
the target has been reﬁned by replacing condensed chromosomes with
extended chromatin ﬁbres (‘Fibre-FISH’; Heng et al., 1992; Wiegant
et al., 1992; Parra and Windle, 1993). Furthermore, Fibre-FISH is now
facilitated by an automated procedure called ‘molecular combing’
(Michalet et al., 1997). Alternative targeted approaches have simpliﬁed
CNV detection (Feuk et al., 2006). For example, ‘real-time qPCR’
(Bieche et al., 1998) and ‘MLPA’ (multiplex ligation-dependent probe
ampliﬁcation) are broadly used to detect recurrent events in clinical
genetics (Schouten et al., 2002). While these different approaches are
restricted to speciﬁc regions, some FISH-based techniques have been
developed to detect genomic aberrations at the whole-genome level
without prior knowledge (Table 1). For example, copy number
differences between two genomes can be detected using ‘comparative
genomic hybridisation’ (CGH; Kallioniemi et al., 1992); and subtle
translocations and complex rearrangements can be characterised using
techniques derived from chromosome painting such as ‘M-FISH’
(multiplex-FISH; Speicher et al., 1996) and ‘SKY’ (spectral karyotyp-
ing; Schrock et al., 1996) where all chromosomes are differentially
coloured in a single experiment (Darai-Ramqvist et al., 2006; Stephens
et al., 2011). These methods are experimentally demanding, labour-
intensive and the resolution still limited by the use of chromosomes as
targets (Table 1).
Precise determination of SV boundaries is crucial for accurate
genotype–phenotype correlations, which are dependent on the
extent of genes or regulatory regions that are disrupted or vary in
copy number (Huang et al., 2010). In addition, nucleotide breakpoint
resolution gives insights into the mechanisms underlying SV
formation (Korbel et al., 2007; Gu et al., 2008; Kidd et al., 2008;
Conrad et al., 2010a; Stankiewicz and Lupski, 2010; Mills et al.,
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www.nature.com/hdy2011). Completion of the human genome sequence in the early
2000s (Lander et al., 2001; Venter et al., 2001) and progress in
molecular biology techniques gave rise to new genome-wide screening
methods, revolutionising the understanding of the genomes of
healthy individuals (Iafrate et al., 2004; Sebat et al., 2004; Redon
et al., 2006; Conrad et al., 2010b) as well as patients with disease. In
this review, we will discuss how microarray and next-generation
sequencing (NGS) technologies can be utilised to reveal and exten-
sively characterise chromosome rearrangements. While the focus of
this review is on humans, since the majority of techniques presented
here have largely been developed to study human genomes, these
new advances are species-independent and hold great promise for
future studies in various areas, including karyotype evolution and
phylogenomics (Grifﬁn et al., 2008; Skinner et al., 2009; Volker et al.,
2010).
ARRAY-BASED TECHNIQUES
A brief introduction to arrays
DNA microarrays or ‘chips’ are currently applied to a wide range of
applications in molecular biology. Originally developed for gene
expression proﬁling, they are now commonly used to unmask
copy number changes (array-based CGH), for single-nucleotide
polymorphism (SNP) genotyping, as well as to study DNA methyla-
tion, alternative splicing, miRNAs and protein–DNA interactions
(array-based ChIP (Chromatin ImmunoPrecipitation)). In short,
each array consists of thousands of immobilised nucleic acid sequences
(for example, oligonucleotide probes or cloned sequences). Labelled
DNA or RNA fragments are applied to the array surface, allowing
the hybridisation of complementary sequences between ‘probes’
and ‘targets’. The main advantages of this technology are its sensitivity,
speciﬁcity and scale as it enables data for thousands of relevant
genomic regions of interest to be generated rapidly in a single
experiment. Lastly, but important for precious clinical samples,
the amount of input sample material required is generally low,
usually o1mg.
CNV discovery using CGH and SNP arrays
While CGH arrays were fabricated speciﬁcally for the detection of
CNVs in genomes, SNP arrays, initially designed for large-scale
genotyping and essential for linkage and association studies, can
also be used for this purpose. The genome-wide coverage of features
on these arrays allows the discovery of CNVs without any prior
knowledge. Some commercial arrays are designed to more easily
identify recurrent rearrangements (in particular microdeletion syn-
dromes) or to genotype CNVs present in 41% of the general
population (known as copy number polymorphisms, CNP; Alkan
et al., 2011a). A list of current commercial human catalogue oligo-
nucleotide arrays is provided in Supplementary Table S1, and arrays
are also available for multiple organisms. In addition, array vendors
generally provide ﬂexibility in design such that the researcher can
easily adapt the content of the array in order to increase the resolution
in one or more regions relevant for their study (‘custom designs’).
Array-CGH. The ﬁrst array-based CGH experiments (Solinas-Toldo
et al., 1997; Pinkel et al., 1998) were designed to improve the
resolution obtained with conventional CGH (Kallioniemi et al.,
1992). Normal metaphase chromosomes were replaced with arrays
containing thousands of DNA sequences. Initially, these sequences
were large genomic clones of typically 80–200kb in length, namely
BAC or PAC (bacterial/P1-derived artiﬁcial chromosome) clones
selected throughout the genome at 1-Mb intervals (B3000 BAC
clones per array) (Snijders et al., 2001; Fiegler et al., 2003a; Chung
et al., 2004). In 2004, the ﬁrst whole-genome tiling path array was
created (Ishkanian et al., 2004). This array comprised 430000 over-
lapping BAC clones covering the entire genome, increasing the array
resolution and the potential to detect copy number changes. Array
resolution has further improved since technology has allowed an
increase in the number of features present on an array and shorter
sequences have been used as targets: cDNA (Pollack et al., 1999;
Heiskanen et al., 2000), PCR amplicons (Mantripragada et al., 2004;
Dhami et al., 2005) and above all, oligonucleotide probes that are now
Table 1 Evolution of genome-wide methods for identifying different classes of chromosomal rearrangements










Early 1970s Karyotyping/G-banding Yes Yes Yes Yes Yes No Low (4several Mb) Low
FISH-based
Early 1990s CGH Yes No Yes No No No Low (4several Mb) High
Mid 1990s M-FISH/SKY/COBRA Yes Yes Yes Yes No No Low (4several Mb) High
Late 1990s RxFISH Yes Yes Yes Yes Yes No Low (4several Mb) High
Array-based
Early 2000s 1-Mb BAC array-CGH Yes No Yes No No No Average (41Mb) High
Tiling-path BAC array-CGH Yes No Yes No No No High (450–100kb) High
Oligonucleotide array-CGH Yes No Yes No No No High (catalogue 41kb,
custom 4400bp)
Very high
Late 2000s SNP arrays Yes No Yes No No Yes High (45–10kb) High
NGS-based Yes Yes Yes Yes Yes Yes Very high (bp level) Very high
Abbreviations: BAC, bacterial artiﬁcial chromosome; CGH, comparative genomic hybridisation; COBRA, combined binary ratio labelling; FISH, ﬂuorescence in situ hybridisation; LOH, loss of
heterozyogosity; M-FISH, multiplex FISH; NGS, next-generation sequencing; RxFISH, Rainbow cross-species FISH or cross-species colour banding; SNP, single-nucleotide polymorphism; SKY,
spectral karyotyping; UPD, uniparental disomy.
Methods in the grey-shaded area are discussed in this review.
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Hereditywidely used (Brennan et al., 2004; Carvalho et al., 2004). This recent
signiﬁcant increase in array resolution has allowed the detection of
genetic imbalances as small as just a few kilobases in size and also
enables the boundaries of an imbalance to be better deﬁned.
In array-CGH, test and reference DNAs are labelled with different
ﬂuorophores (for example, Cy5 and Cy3), and then simultaneously
hybridised onto arrays in the presence of Cot-1 DNA to reduce the
binding of repetitive sequences (Figure 1). If only low amounts of
DNA are available (for example, in prenatal diagnosis or tumour
analysis), ampliﬁcation methods can be applied before labelling
(Guillaud-Bataille et al., 2004; Le Caignec et al., 2006; Fiegler et al.,
2007) although data quality is in general substantially reduced
(Talseth-Palmer et al., 2008; Przybytkowski et al., 2011). After hybri-
disation, washing and scanning, Cy5 and Cy3 ﬂuorescence intensities
are measured for each feature on the array, normalised, and log2 ratios
of the test DNA (for example, Cy5) divided by the reference DNA (for
example, Cy3) are then plotted against chromosome position. Theo-
retically, for each position, a value of 0 indicates a normal copy
number (log2 (2/2)¼0) result, while a log2 ratio of 0.58 (log2
(3/2)¼0.58) indicates a one copy gain in test compared with reference,
and a log2 ratio of  1 (log2(1/2)¼ 1) indicates a one copy loss in test
compared with reference. To minimise the inﬂuence of CNVs in the
reference DNA for the identiﬁcation of CNVs in the test DNA, a pool
of ‘normal’ DNA samples, ideally 4100, can be used as a reference. A
large variety of algorithms designed to detect CNVs from array-CGH
data (‘calling’ algorithms) have been published, for example, ‘DNA-
copy’ (Olshen et al., 2004), ‘SW-ARRAY’ (Price et al., 2005), ‘SMAP’
(Andersson et al., 2008), ‘GADA’ (Pique-Regi et al., 2008) and ‘ADM3’
(R package available at http://cran.r-project.org). These algorithms
search for intervals where the average log2 ratio exceeds speciﬁed
thresholds. If probe response is good and background noise is low, a
few probes can be sufﬁcient to detect imbalanced regions with
conﬁdence (generally a minimum of 3–10 probes are used, depending
on platforms; Alkan et al., 2011a). Algorithms can more accurately
detect CNVs and will produce less false positive calls if data are
normalised to correct for artefacts such as GC-bias, waves (Marioni
et al., 2007) or dye-bias (Fitzgerald et al., 2011).
Commercial arrays (Supplementary Table S1) provided by
companies such as Agilent Technologies (Santa Clara, CA, USA)
BlueGnome (Cambridge, UK) Oxford Gene Technology (Oxford,
UK) and Roche NimbleGen (Madison, WI, USA) in the UK, offer
robustness, sensitivity and ﬂexibility compared with early BAC arrays.
As previously stated, the researcher can order a custom design
including dense coverage focusing on single or multiple chromosomal
regions where higher resolution is required. Conrad et al.( 2 0 1 0 b )
describe the use of a set of 20 ultra-high resolution oligonucleotide
arrays comprising 42 million probes in total, with a median probe
spacing of just 56bp across the entire genome. Such high resolution
enabled the identiﬁcation of 11700 CNVs 4443bp in the genomes of
40 normal individuals. The fabrication processes of the arrays vary
between manufacturers. For example, Agilent Technologies utilises in
situ inkjet technology (‘SurePrint Technology’, Agilent Technologies)
to synthesise 60-mer oligonucleotide array features (Barrett et al.,
2004). This technology produces highly reproducible features and
excellent signal-to-noise ratios, assuring maximum sensitivity and
speciﬁcity. Custom arrays can be designed and ordered using the
online eArray application (https://earray.chem.agilent.com/earray/),
which contains at present over 28 million in silico-validated human
Figure 1 Overview of ‘cytogenetics’ oligonucleotide arrays workﬂow. White boxes: sample preparation stage, grey boxes: microarray stage. Different methods
are available for array-CGH labelling (enzymatic, restriction digestion, Universal Linkage System) and can require a fragmentation step (dashed line box).
Hybridisation mixtures contain blocking agents and DNA enriched for repetitive sequences (for example, Cot-1 DNA) to block nonspeciﬁc hybridisation and
reduce background signal. Hybridisation times vary according to platform and array format. For further details on protocols see the commercial vendors’
website. Available catalogue arrays are listed in Supplementary Table S1. Cy5, cyanine-5; Cy3, cyanine-3; gDNA, genomic DNA; OGT, Oxford Gene
Technology; WGA, whole-genome ampliﬁcation.
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Heredityoligonucleotide sequences. These 60-mers span exonic, intronic,
intergenic, pseudoautosomal, segmented duplication DNA regions
and copy number variable regions. In addition to sequences contained
in the database, any custom oligonucleotide sequence with a size
ranging from 25 to 60bp can be printed. For every oligonucleotide on
the array, scores can be provided by array manufacturers, which can
predict their performance on a genomic array and help to interpret
derivative log2 ratio values in breakpoint regions (Sharp et al., 2007).
Scores are based on various parameters such as melting temperature
(Tm), SNP content, sequence complexity and uniqueness of the
oligonucleotide sequence. For cost-effectiveness, the user can choose
between different layouts, from 8 60K up to 1 1 M for SurePrint G3
arrays (Supplementary Table S1). Furthermore, designs can be shared
with collaborators through the online application. Roche NimbleGen
high-density array manufacturing is based on photo-mediated
synthesis process using the Maskless Array Synthesizer technology
(Nuwaysir et al., 2002). In comparison to other in situ synthesis
technologies such as inkjet deposition, this method enables the
production of more features on the glass slide, and oligonucleotide
lengths are usually ranging between 50 and 75bp. They have
recently introduced very high-resolution arrays composed of 4.2
million array features (284bp median feature spacing), and different
array formats are also available (Supplementary Table S1). The
array design is made on-demand by Roche NimbleGen from a list
of regions of interest supplied by the customer. Similar to Agilent
Technologies, Roche NimbleGen offers whole-genome catalogue
arrays and custom solutions designed to study a range of various
organisms.
SNP arrays. As with array-CGH technology, SNP arrays have under-
gone huge developments over the last few years (Kennedy et al., 2003;
Gunderson et al., 2005; LaFramboise, 2009), with the ability to
genotype a few thousands SNPs at ﬁrst, rising to millions of SNPs
today in the latest arrays. In addition to the advances in resolution, the
design of the arrays is continually incorporating more informative
SNPs, as a result of large-scale studies such as the HapMap Project
(The International HapMap Consortium, 2003) and the 1000 gen-
omes project (Durbin et al., 2010). Although SNPs account for a
substantial part of genetic variation, chromosomal rearrangements
have a tremendous role in disease, evolution and tumourigenesis, and
SNP arrays have progressively started to be used to simultaneously
genotype SNPs and detect rare and common genomic rearrangements
(Bignell et al., 2004; Huang et al., 2004; Peiffer et al., 2006). Besides
ampliﬁcations and deletions detected by both CGH and SNP arrays,
SNP arrays can reveal mosaicism, extended regions of loss of hetero-
zygosity, uniparental disomy (Conlin et al., 2010), provide more
accurate calculation of copy numbers (Greenman et al., 2010) and
determine parental origin of de novo CNVs (Conlin et al., 2010) in
trios. Unlike array-CGH, which relies on co-hybridisation of test and
reference DNA, only the test sample is hybridised onto each SNP array
(Figure 1). The copy-number analysis of SNP array data generally uses
two parameters, comparing observed test sample values to expected
r e f e r e n c ev a l u e s ,t h eL o g 2 R intensity ratio, and the allelic intensity
ratio or ‘B-allele frequency’ (Peiffer et al., 2006; Alkan et al., 2011a).
Many algorithms have been developed and are often speciﬁc to array
types (Winchester et al., 2009; Dellinger et al., 2010; Pinto et al., 2011).
To improve the efﬁciency of CNV discovery with SNP arrays,
manufacturers have included nongenotyping, nonpolymorphic mar-
kers in their designs, which are speciﬁcally designed to detect CNVs
with greater performance, as well as increasing marker density in CNV
regions (Supplementary Table S1). For example, half of the 1.8 million
markers of the human Affymetrix 6.0 array are dedicated to the
identiﬁcation of copy-number variation (McCarroll et al., 2008).
Should SNP arrays replace CGH arrays? Despite the variety of
information obtained in a single experiment, greater potential for
automation and scalability, SNP arrays generally do not perform as
well as dedicated CGH arrays for copy-number variation discovery, in
terms of sensitivity and resolution (Cooper et al., 2008; Curtis et al.,
2009; Alkan et al., 2011a; Pinto et al., 2011). To conclude, the choice of
platform should be dependent on the project. If looking for very small
deletions (o50kb) or gains, array-CGH would probably be the best
option. However, for cancer genetics or human diseases linked to
uniparental disomy, for example, Prader–Willi and Angelman syn-
dromes (Yamazawa et al., 2010), SNP arrays could be more appro-
priate. Recently, several companies have been developing hybrid arrays
designed both for copy-number analysis and for detection of mosai-
cism, loss of heterozygosity, uniparental disomy or regions identical by
descent, using allelic difference features (‘CGH+SNP’ array and
‘cytogenetics’ array) (Figure 1; Supplementary Table S1). However,
the performance of these platforms is not widely reported to date and
they have not yet been included in platform comparison studies.
Fine-mapping of translocation breakpoints using array painting
Although array-CGH can be used to reveal deletions and ampliﬁca-
tions, including imbalances associated with apparently balanced
translocation, they are unable to detect balanced rearrangement events
such as inversions and balanced reciprocal translocations. Balanced
reciprocal translocations are carried constitutionally by 1 in 500
individuals and also occur frequently in cancer cells (Howarth et al.,
2008). Disruption of regulatory regions such as enhancers or genes,
and creation of fusion transcripts by a chromosome translocation can
have phenotypic consequences. In this section, we will describe the
‘array painting’ technique, which combines ﬂow-sorting of derivative
chromosomes and array-CGH to map translocation breakpoints and
identiﬁes more accurately gene disruption.
Array painting is a technique derived from reverse chromosome
painting (Carter et al., 1992) and array-CGH technologies, developed
to rapidly characterise reciprocal chromosome translocation break-
points (Fiegler et al., 2003b) (Figure 2). In reverse chromosome
painting, probes are generated by DOP-PCR (degenerate oligonucleo-
tide primed PCR; Telenius et al., 1992) from isolated aberrant
chromosomes, and hybridised onto normal metaphase spreads using
FISH. This enables the identiﬁcation of chromosomal regions present
in the aberrant chromosome, and to locate the approximate positions
of the breakpoints. As with conventional CGH (Kallioniemi et al.,
1992), using metaphase chromosomes as a target limits the resolution
of reverse painting and breakpoints can only be localised at a
resolution of 5–10Mb. In order to increase accuracy, metaphase
chromosomes have been replaced by arrays (Fiegler et al., 2003b).
First, the two aberrant or ‘derivative’ chromosomes involved in the
reciprocal translocation are isolated. This can be achieved by ﬂow-
sorting (Gribble et al., 2009) or by microdissection (Backx et al.,
2007). Subsequently, each derivative chromosome, represented by one
(Gribble et al., 2004) or generally multiple copies, is ampliﬁed using
DOP-PCR or commercially available whole-genome ampliﬁcation kits
to provide sufﬁcient DNA. The ampliﬁed products are then differen-
tially labelled with ﬂuorescent dyes (Cy5 and Cy3), and co-hybridised
onto an array, which is then scanned after excess labelled probe is
washed off (Figure 2). As for array-CGH, log2 ratios for Cy5/Cy3
intensities are plotted against chromosome position for each feature.
Because the chromosomal regions ﬂanking each side of the breakpoint
are differentially labelled as they are present on different derivative
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Hereditychromosomes, the position where the log2 ratios changes from high to
low ratios (or vice versa) deﬁnes the breakpoint, and breakpoint
spanning clones usually show intermediate ratios (Fiegler et al., 2003b;
Backx et al., 2007) (Figure 2). Fine-mapping of breakpoints is only
dependent on the resolution of the array. In the initial reports of the
array painting method, 1-Mb whole-genome or custom tiling BAC
arrays were used (Fiegler et al., 2003b). Array painting beneﬁted from
the evolution of array-CGH technology and BAC arrays have been
replaced by whole-genome or region-speciﬁc high-resolution oligo-
nucleotide arrays, allowing higher resolution and better accuracy of
breakpoint determination (Gribble et al., 2007). Precise breakpoint
mapping of balanced translocations can give insights into associated
phenotypes in patients. For example, array painting performed with a
244K CGH array for a t(10;13)(q22;p13) balanced translocation
suggested that C10orf11, which was disrupted by the translocation,
could contribute to the mental retardation phenotype in 10q22
deletion patients (Tzschach et al., 2010). Breakpoints identiﬁed by
array technologies can be independently validated by FISH assays to
visually demonstrate the rearrangements in individual cells.
This robust procedure can be used to determine the composition of
any isolated chromosome and has applications other than mapping
balanced translocation breakpoints. Thus, complex chromosome
rearrangements, involving more than two chromosomes, can be
deciphered (Fauth et al., 2006), and in some instances other inter-
chromosomal aberrations may be identiﬁed. Furthermore, array
painting can replace conventional chromosome painting to determine
cross-species homology, which can give insights into karyotype
evolution. For example, white-cheeked gibbon chromosome 14 was
hybridised onto a human 1-Mb array, which identiﬁed syntenic blocks
on human chromosomes 2 and 17 (Gribble et al., 2004).
An alternative technique to array painting for ﬁne-mapping of
translocation and complex rearrangements breakpoints, based on
‘Chromatin Conformation Capture on Chip’ or 4C (Simonis et al.,
2009) has been described. Brieﬂy, many fragments across the break-
points are captured by cross-linking physically close parts of the
genome, followed by restriction enzyme digestion, locus-speciﬁc
inverse PCR and templates hybridised to 4C-tailored microarrays.
Clustering of positive signals displaying increased intensities predicts
breakpoints at the resolution of the array. It claims to be particularly
valuable if isolation of derivative chromosomes is not achievable, and
to characterise inversions.
NGS-BASED TECHNIQUES
A brief introduction to NGS
Using conventional Sanger sequencing, it has taken more than a
decade of international effort to sequence the human genome (Lander
et al., 2001; Venter et al., 2001). Since the development of NGS (or
‘second-generation’ sequencing) technologies in 2005, sequencing of a
whole human genome can now be achieved in a few days and at much
lower cost. Also known as ‘massively parallel sequencing’, these
technologies allow the sequencing of millions of DNA molecules
simultaneously after library preparation of fragments, to produce
sequence reads. Sequence reads are generally aligned to the reference
genome and base variants, small insertions/deletions (indels) and SVs
(450bp) can be detected. The most commonly used platforms at
present have been developed by Illumina (Genome Analyzer/HiSeq,
Figure 2 Overview of array painting workﬂow. White boxes: sample preparation stage, grey boxes: microarray stage. BAC, bacterial artiﬁcial chromosome;
WGA, whole-genome ampliﬁcation. For further details see Gribble et al. (2009).
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HereditySan Diego, CA, USA), Roche (454 Life Sciences, Branford, CT, USA)
and Applied Biosystems/Life Technologies (SOLiD, Foster City, CA,
USA) and these as well as others are reviewed by Metzker (2010). In
addition to high-throughput resequencing for understanding human
genome variation and diseases, this technology has opened the door to
a wide range of applications such as large-scale gene expression studies
using RNAseq, and whole-genome sequencing of many organisms,
which has a huge impact on evolutionary knowledge. NGS technol-
ogies are still under development and third-generation platforms
could produce reads reaching up to a few kilobases whereas read
lengths presently range from B30 to B400bp depending on the
platform (Metzker, 2010). Until whole-genome sequencing becomes
more economical, speciﬁc genomic regions can be isolated for
sequencing, for example, chromosomes or derivative chromosomes
can be isolated by ﬂow-sorting, or regions of interest can be selected
from the genome by sequence capture (also termed ‘pull-down’ or
‘enrichment’; Coffey et al., 2011; Hedges et al., 2011). Another way to
make NGS more cost-effective when working with small genomes or
speciﬁc genomic regions is to add a unique oligonucleotide ‘tag’ or
‘index’ to samples before multiplexing and sequencing (Parameswaran
et al., 2007).
Deciphering chromosomal rearrangements with NGS technology
Information provided by read mapping and sequence coverage enables
the detection of SVs and NGS is becoming an attractive alternative to
array-based assays in the ﬁeld of molecular cytogenetics. Among the
many advantages of high-throughput NGS, SVs of all types and sizes
can theoretically be detected, breakpoints can be mapped with high
resolution, down to the basepair level in some instances, and complex
rearrangements can be characterised with the possibility to study
multiple breakpoints in a single experiment. Four different approaches
have been described to characterise SVs: (i) read-depth analysis, which
can only detect gains and losses; (ii) read-pair analysis (paired-end
mapping); (iii) split-read analysis; and (iv) assembly methods, all of
which can detect in theory all types of rearrangements including copy-
neutral rearrangements (inversions and translocations) (Figure 3). A
variety of tools based on one or more of these methods have been
developed to analyse chromosomal rearrangements according to the
genomic regions affected, the size-range and breakpoint precision
(Medvedev et al., 2009; Alkan et al., 2011a; Mills et al., 2011). We will
discuss how each method can be used to characterise genomic
rearrangements, with the exception of local assembly approaches
that are still limited by read length and cost (Alkan et al., 2011b).
Read-depth method. Read-depth NGS data (Campbell et al., 2008;
Chiang et al., 2009; Yoon et al., 2009) are essentially providing similar
information to that obtained from array-CGH, by indicating copy-
number gains (42 copies for a diploid genome) or losses (o2
copies). Sequence read depth, that is, the number of reads mapping
at each chromosomal position, is in theory randomly dispersed and
signiﬁcant divergence from the normal Poisson distribution indicates
copy-number variation (Figure 3). Duplications and ampliﬁcations
are indicated by the presence of regions showing excessive read depth,
whereas low read depth indicates heterozygous deletion and absence
of coverage is suggestive of homozygous deletion. Statistical power is
limited for smaller CNVs but increasing sequence coverage can in
some instances improve sensitivity (Chiang et al., 2009). Factors such
as GC content, homopolymeric stretches of DNA or preferential PCR
ampliﬁcation at the library preparation stage can introduce biases.
Repetitive DNA regions are also problematic as reads are aligned with
low conﬁdence (low ‘mapping quality’; Li et al., 2008), providing poor
information on copy-number status, but longer reads will increase
mapping speciﬁcity in the future. Applying read-depth analysis to
cancer cell lines has shown that the dynamic range for absolute
copy-number evaluation is greater than that detected by SNP arrays
(Campbell et al., 2008), which tend to saturate for high intensity
values. For example, Chiang et al. (2009) found a 55.6-fold increase by
NGS compared with only a 16-fold increase by SNP array for the
ERBB2 locus in a breast carcinoma cell line. This increased dynamic
range of NGS may lead to new insights into segmental duplications
(Alkan et al., 2009) and multicopy gene families (Sudmant et al.,
2010).
Read-pair method. Currently, the most powerful method to study
chromosome rearrangements is the paired-end read mapping techni-
que (Tuzun et al., 2005; Korbel et al., 2007) (Figure 3). Sequence read
pairs are short sequences from both ends of each of the millions of
DNA fragments (‘inserts’) generated by library preparation. Clustering
of at least two discordant pairs of reads, either by size or by
orientation, is suggestive of a chromosome rearrangement. When
aligned to the reference genome, read pairs (4o)a r ee x p e c t e dt o
map at a certain distance (4----o - 4----o) corresponding to
the average library insert size (typically 200–500bp and up to 5kb for
large-insert libraries); a spanning distance signiﬁcantly different from
the average insert size indicates putative SVs. Deletions are identiﬁed
by read pairs spanning a longer genomic region when mapped to the
reference not carrying the deletion (4–(del)–o - 4--------o).
By contrast, insertions or tandem duplications in the sequenced
sample will cause the reads to map closer as they are absent from
the reference genome (4-(ins/dup)-o - 4–o). In addition to the
expected span distance of a sequence read pair, aberrant mapping
orientation can identify inversions (4----4) and tandem duplica-
tions (o----4)( K o r b e let al., 2007; Kidd et al., 2008) (Figure 3).
Novel insertions, as compared with published reference genomes, are
identiﬁable when only one read of the pair is mapping (o----).
Data from short-insert libraries often need to be supplemented by
data from large-insert libraries generated by large circular fragments of
DNA typically of 2–5kb, providing higher physical coverage at break-
points thereby facilitating SV detection (Shendure et al., 2005; Bentley
et al., 2008) (Figure 4). Short-insert libraries (200–500bp) have a
limited capacity to detect SVs mediated by segmental duplications (or
low-copy repeats) that harbour a substantial part of SVs (Sharp et al.,
2005; Cooper et al., 2007; Kidd et al., 2008; Conrad et al., 2010a),
because reads map to multiple similar genomic locations (Li et al.,
2008). Another example is the limit to detect insertions larger than the
library insert size. Conversely, small events (o400bp) can be missed
with large-insert libraries because the expected size variance between
the mate pairs will not be signiﬁcantly altered. The lower resolution
associated with large-insert libraries can also mistake complex events,
where several breakpoints are in close proximity such as small inver-
sions ﬂanked by deletions, for simple deletions (Bentley et al., 2008).
Split-read method. The third approach commonly applied to NGS
data is the split-read method (Figure 3). Although this method was
originally developed for Sanger sequencing (Mills et al., 2006) and will
be much more efﬁcient with longer read length, it is already capable of
precisely mapping breakpoints for small deletions (1bp–10kb) in
unique regions of the genome using the algorithm Pindel (Ye et al.,
2009) and read lengths as low as 36bp. The ﬁrst stage is to map all
reads to the reference genome, and select read pairs responding to the
following criteria: one read maps perfectly (no mismatches) and
uniquely (no other genomic location), and the other read of the
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Hereditypair cannot be mapped (that is, it is across the rearrangement
breakpoint). For each of these pairs, using the location and orientation
of the mapped read, Pindel searches for the paired unmapped read
(‘split’ read) by performing multiple local alignments. In the case of
deletions, candidate unmapped reads are split into two fragments that
map separately, and analysis of the alignment deciphers the breakpoint
at the basepair level. The AGE algorithm described recently has been
designed to identify exact breakpoints for tandem duplications,
inversions and complex events (Abyzov and Gerstein, 2011). Thus,
this method has a signiﬁcant advantage on others applied to array or
NGS data, which can identify breakpoints with high resolution
(Gribble et al., 2007; Mills et al., 2011) but require an additional
PCR or high-throughput capture step (Conrad et al., 2010a; Mills
et al., 2011) followed by conventional or NGS to reach basepair
resolution.
Fine-mapping of translocation breakpoints using NGS. In one of the
ﬁrst studies applying NGS to ﬁne map a reciprocal translocation
breakpoint, derivative chromosomes were isolated by ﬂow-sorting,
sequenced and single-end reads aligned to the two corresponding
chromosomes (Figure 4a). Read-depth analysis identiﬁed breakpoints
within 1kb, which were subsequently conﬁrmed at the basepair
level by PCR ampliﬁcation and sequencing (Chen et al., 2008). With
whole-genome sequencing becoming more affordable and paired-end
Figure 3 Four methods to identify SVs from NGS data. These methods are often used in combination to detect chromosomal rearrangements and
characterise breakpoints (red arrows) with precision. De novo assembly methods are still challenging but have the potential to accurately and rapidly
characterise all classes of rearrangements. MEI, mobile-element insertion; RP, read pair. For further details and full ﬁgure legend, see Alkan et al., 2011a.
Reprinted by permission from Macmillan Publishers Ltd: Nature Reviews Genetics (Alkan et al., 2011a), copyright 2011.
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Hereditytechnology now available, ﬂow-sorting of derivative chromosomes
becomes less critical, as essentially, pairs of reads mapping to different
chromosomes will identify translocations (Figures 4b and c; Slade
et al., 2010). Large-insert paired-end libraries (Figure 4c) of B3kbare
generally preferred to short-insert libraries to increase physical cover-
age, and maximise chances of observing read pairs consistently
spanning the breakpoint (Chen et al., 2010; Slade et al., 2010). If
high sequence coverage is reached and reads span the breakpoint
(‘split’ reads) (Figure 4), it should be straightforward to directly
identify the exact breakpoint without the need for an extra PCR/
sequencing step. For example, a method called SLOPE can rapidly
identify sequence breakpoints for translocations using read-depth and
split-read data (Abel et al., 2010).
Insights from cancer genomes. NGS has also revolutionised the
understanding of cancer genomes by identifying not only the full
spectrum of somatic point mutations (Mardis et al., 2009; Pleasance
et al., 2010) but also giving more insights into complex whole-genome
acquired rearrangements (Campbell et al., 2008; Stephens et al., 2009)
(Figure 5). These studies showed that intra- and inter-chromosomal
somatic rearrangements can be detected and are more frequent than
envisaged, partly because they involve small aberrations beyond the
resolution of previous molecular cytogenetics methods, emphasising
the utility of NGS to study rearrangements (Meyerson et al., 2010).
Discovery of fusion genes resulting from these rearrangements and
having potential functional consequences is greatly facilitated.
Furthermore, transcriptome sequencing using next-generation tech-
nologies can identify or validate putative fusion transcripts in a high-
throughput manner (Maher et al., 2009).
IMPACT ON PRESENT AND FUTURE STUDIES
Recently developed molecular cytogenetic methods have provided new
tools to accurately characterise chromosomal rearrangements and
have uncovered the great complexity of human genome architecture
(Pang et al., 2010). We have shown that each strategy has limitations,
emphasising that approaches often need to be combined to capture
the entire range of genetic variation (Alkan et al., 2011a; Mills et al.,
2011).
Despite the enormous potential of high-throughput sequencing,
array technology has progressed in the past few years and is still
appropriate for a broad range of research projects. In addition to
robustness, ﬂexibility, and low input material required, array technol-
ogies do not demand as many resources as NGS technologies in terms
of equipment and computational power. Arrays also give the possibi-
lity to study a large number of samples in a cost-effective manner. For
example, CNVs identiﬁed in discovery phases can be subsequently
genotyped by arrays in large population samples and used in disease
association studies (Craddock et al., 2010), however data can be less
accurate than sequencing at high-copy number states (Chiang et al.,
2009). Array-based assays have replaced karyotyping for the diagnosis
Figure 4 Mapping translocation breakpoints by NGS. Bars depict sequencing reads mapping to distinct chromosomes (chromosome 1 and chromosome 2)
each side of the translocation breakpoint. Sequence coverage (number of times the breakpoint is covered by sequencing reads) vs physical coverage (number
of times the breakpoint is covered by library fragments) are indicated. (a) Single-end sequencing. (b) Paired-end sequencing from a short-insert library
(o500bp). (c) Paired-end sequencing from a large-insert library (41kb), increasing physical coverage at the breakpoint site and likelihood of characterising
the translocation. Reads spanning the translocation breakpoint are called ‘split reads’ and can identify breakpoints at basepair resolution. Higher depth of
sequence coverage (using short-insert libraries) and longer read lengths theoretically generates more informative split reads. Reprinted by permission from
Macmillan Publishers Ltd: Nature Reviews Genetics (Meyerson et al., 2010), copyright 2010.
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Heredityof developmental disabilities or congenital anomalies (Miller et al.,
2010), and will remain the gold standard method until sequencing
costs drop dramatically and downstream analyses are facilitated.
Array-based methods have revealed an unexpected level of
rearrangement complexity such as imbalances in apparent balanced
translocations (Gribble et al., 2005; Howarth et al., 2011), but they are
mostly restricted to the detection of CNVs, and FISH is still required
to distinguish tandem from dispersed duplications and decode com-
plex rearrangements. Moreover, resolution achieved using arrays can
be limited by the density of features printed on the glass slide and
there has clearly been a bias towards detecting larger events thus far,
even if sets of custom arrays can be employed to increase resolution
(Conrad et al., 2010b; Park et al., 2010). The emergence of techniques
based on high-throughput sequencing is opening new perspectives for
chromosome rearrangement analyses. Whole-genome sequencing is
comprehensive and reveals point mutations, indels, as well as all types
of chromosome rearrangements including balanced events, and can be
used to reconstruct genome architecture. Success of sequencing
approaches is often dependent on obtaining sufﬁcient coverage
because of the relatively high level of sequencing error in NGS.
Current analytical methods mostly rely on sequence alignment against
a unique reference genome, and unspeciﬁc mapping of short reads to
repetitive regions is problematic with many events mediated by
repetitive elements potentially being missed (Conrad et al., 2010a).
However, third-generation sequencing technologies (Metzker, 2010)
will provide longer reads more cheaply, enabling accurate de novo
assembly and will help to overcome these issues.
With the increase in resolution and the larger number of SVs
detected in each genome with current methods, the challenge is now
to infer their phenotypic impact on normal variation and health
(Huang et al., 2010). More resources will be needed to guide the
interpretation, especially with the growing interest for personalised
medicine. Up until now, NGS technologies have largely been applied
to study the human genome, but complete sequencing of more than a
thousand organisms (997 prokaryotes and 39 eukaryotes, May 2011;
http://www.ncbi.nlm.nih.gov/genomes/static/gpstat.html) has now
been completed and hundreds more are in progress. Methods
described in this review can be utilised to detect and comprehend
SV between species or strains and give new insights into recent
evolution.
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